Acromegaly - 140 Studies Found
| Not yet recruiting |
: Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy : Acromegaly Cardiomyopathy : 2015-11-18 : Drug: Tadalafil Tadalafil 20 mg to be taken orally once daily, for 5 months |
| Completed |
: Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism : Acromegaly, Pituitary Gigantism : 2012-08-16 : Drug: SOM230LAR Intramuscular administration of pasireotide LAR will be repeated every month (1 month = |
| Completed |
: Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly : Acromegaly : 2007-03-07 : Drug: lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval Si |
| Active, not recruiting |
: Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly. :
: 2014-03-18 |
| Completed |
: Preoperative Octreotide Treatment of Acromegaly : Acromegaly : 2007-08-24 :
|
| Completed |
: Measurement of Outcome of Surgical Treatment in Patients With Acromegaly : Acromegaly : 2000-04-06 |
| Completed |
: Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly : Acromegaly : 2006-09-06 : Drug: Octreotide acetate 30 mg suspension Each vial of study medication contained octreotide acetate 30 |
| Completed |
: Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects :
: 2012-11-06 : Drug: genotropin iii) intravenous exogenous bolus of GH (0.5 mg) followed by muscle and fat biopsies. |
| Completed |
: Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly : Acromegaly : 1999-10-18 |
| Recruiting |
: Acromegaly Combination Treatment Study : Acromegaly : 2012-02-21 :
|